Head-To-Head Contrast: Revolutions Medical (OTCMKTS:RMCP) and Glaukos (NYSE:GKOS)

Revolutions Medical (OTCMKTS:RMCP) and Glaukos (NYSE:GKOS) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, risk, institutional ownership, analyst recommendations, earnings, profitability and dividends.

Insider & Institutional Ownership

99.0% of Glaukos shares are held by institutional investors. 10.5% of Revolutions Medical shares are held by company insiders. Comparatively, 7.8% of Glaukos shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of current ratings and recommmendations for Revolutions Medical and Glaukos, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Revolutions Medical	0	0	0	0	N/A
Glaukos	0	2	7	0	2.78

Glaukos has a consensus price target of $99.80, suggesting a potential upside of 4.89%. Given Glaukos’ higher probable upside, analysts plainly believe Glaukos is more favorable than Revolutions Medical.

Earnings & Valuation

This table compares Revolutions Medical and Glaukos’ top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Revolutions Medical	N/A	N/A	N/A	N/A	N/A
Glaukos	$314.71 million	15.17	-$134.66 million	($2.78)	-34.23

Revolutions Medical has higher earnings, but lower revenue than Glaukos.

Risk & Volatility

Revolutions Medical has a beta of -0.43, meaning that its share price is 143% less volatile than the S&P 500. Comparatively, Glaukos has a beta of 1.08, meaning that its share price is 8% more volatile than the S&P 500.

Profitability

This table compares Revolutions Medical and Glaukos’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Revolutions Medical	N/A	N/A	N/A
Glaukos	-42.79%	-22.67%	-11.50%

Summary

Glaukos beats Revolutions Medical on 5 of the 9 factors compared between the two stocks.

About Revolutions Medical

Revolutions Medical Corporation, a development stage company, is engaged in the design, development, and commercialization of auto retractable vacuum safety syringes in the United States and internationally. The company develops RevVac auto retractable vacuum safety syringe, which is designed to reduce accidental needle stick injuries and lower the spread of blood borne diseases. It is also developing a suite of magnetic resonance imaging software tools consisting of RevColor, Rev3D, RevDisplay, and RevScan that are designed to enhance general diagnostic confidence through education and research use. The company sells its products to acute care hospitals, alternate care facilities, doctors' offices, clinics, emergency centers, surgical centers, convalescent hospitals, veterans administration facilities, military organizations, public health facilities, and prisons through distributors. Revolutions Medical Corporation was founded in 1996 and is headquartered in Charleston, South Carolina.

About Glaukos

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.